British journal of haematology 2021 Sep 29
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy.
Related Questions
Caplacizumab is not FDA approved in pregnant patients, but has been used safely in isolated case reports.
New answer by Medical Oncologist at Duke University School of Medicine (October 1, 2024)
As noted, caplacizumab was not studied in pregnancy (was an exclusion criteria) and is not approved in this setting.With that being said, as noted, caplacizumab use in pregnan...